VictoriaEClarkMDPhD

Brain & Spinal Tumor, Skull Base

Physician

Dr. Clark is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Texas M D Anderson Cancer CenterFellowship, Neurosurgical Oncology, 2023 - 2024
Massachusetts General HospitalResidency, Neurological Surgery, 2016 - 2023
Yale School of MedicineClass of 2016
Harvard UniversityBA, Biochemical Sciences, High Honors, 2004 - 2008

Journal of Neuro-Oncology Award AANS/CNS Section on Tumors, 2023
Sherry Apple Resident Travel Scholarship CNS/WINS, 2023
Second Place, Division of Surgery Clinical Trials Design Course University of Texas MD Anderson Cancer Center, 2023
Senior Resident Clinical Excellence Award MGH Neurosurgery, 2022
Integra Foundation Award American Association of Neurological Surgeons, 2021
MD/PhD Thesis Prize Yale School of Medicine, 2016
Doctor of Medicine cum laude Yale University School of Medicine, 2016
Nominee, Council of Graduate Schools/Proquest Distinguished Dissertation Award Interdepartmental Neuroscience Program, Yale University, 2015
One of three studies honored for advances in Central Nervous System Cancers Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer, American Society of Clinical Oncology, 2013
Outstanding Senior Thesis Thomas Templeton Hoopes Prize, 2008
Four-year lab fellowship Howard Hughes Medical Institute, 2005-2008
Summer Fellowship David Rockefeller Center for Latin American Studies, 2006
Join now to see all

PubMed

91 citations
Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis
E. Zeynep Erson-Omay, Ahmet Okay Caglayan, Nikolaus Schultz, Nils Weinhold, S. Bulent Omay
Neuro-Oncology. 2015-10-01
69 citations
Integrated genomic analyses of de novo pathways underlying atypical meningiomas.
Akdes Serin Harmancı, Mark W Youngblood, Victoria E Clark, Süleyman Coşkun, Octavian Henegariu
Nature Communications. 2017-02-14
219 citations
Integrated genomic characterization of IDH1 -mutant glioma malignant progression
Hanwen Bai, Akdes Serin Harmanci, E. Zeynep Erson-Omay, Jie Li, Süleyman Coşkun
Nature Genetics. 2016-01-01

Books/Book Chapters

Genomics, Circuits, and Pathways in Clinical Neuropsychiatry
Chapter: Genomic Landscape of Brain Tumors
Page 653 - 663Clark V, Youngblood M, Bai H, Gunel GM, Gunel MEditors: Lehner T, State MW.Academic PressEdition 2,2016
Cancer: Principles & Practice of Oncology: Primer of the Molecular Biology of Cancer
Chapter: Molecular Biology of Central Nervous System Tumors
Clark V, Gunel JM, Gunel MWolters KluwerEdition 2,2015
DeVita, Hellman, and Rosenberg's Cancer : Principles and Practice of Oncology
Chapter: Molecular Biology of Central Nervous System Tumors
Clark V, Gunel JM, Gunel MWolters KluwerEdition 10,2014

Lectures

RNA Polymerase II Meningioma Mutations Activate Forebrain Neurodevelopmental Pathways
Congress of Neurological Surgeons (CNS) Annual Meeting - 2023
EZH2 Inhibition Decreases SMARCB1 and NF2 Mutant Meningioma Cell Viability Oral Presentation
Congress of Neurological Surgeons (CNS) Annual Meeting - 2022
RNA Pol II Mutations Dysregulate Transcriptional Pause-Release and Exhibit Susceptibility to CDK9 Inhibition
American Association of Neurological Surgeons (AANS) Annual Meeting - 2021
Characterizing the Genomic Architecture and Molecular Mechanisms Driving the Formation of Non-NF2 Meningiomas
211th Meeting of the Interurban Clinical Club - 2015
Genomic Analysis of TRAF7-only Mutant Meningiomas Reveals Novel Driver Mutations
World Federation of Neuro-Oncology, Fourth Quadrennial Meeting - 2013
Join now to see all

Andrew T. Parsa Research FellowshipNeurosurgery Research and Education Foundation (NREF)2020–2022
Peer Reviewed Cancer Research Program (PRCRP) Horizon AwardDepartment of Defense2020–2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral MD/PhD or Other Dual-Doctoral Degree Fellowship (F30)NIH/National Cancer Institute2014–2016